UBS Group
PRXL

UBS Group’s Parexel International Corp PRXL Stock Holding History

UBS Group’s Portfolio PRXL Stock Details PRXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$7K – 9106
2015
Q1 		$7K Sell
100
-1,400
-93% -$89.2K ﹤0.01% 7959
2014
Q4 		$83K Buy
+1,500
New +$86.5K ﹤0.01% 5903

Other funds holding PRXL

RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return

UBS Group's PRXL Position: Q4 2017 in Review

UBS Group sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 537,867 shares — an estimated $47.4M sold.

UBS Group first reported a position in PRXL in Q4 2014 and held it in 12 quarters. The position peaked at $218M in Q3 2016. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.

  • UBS Group reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
  • UBS Group sold 537,867 Parexel International Corp shares in Q4 2017, an estimated $47.4M.
  • UBS Group first reported a position in Parexel International Corp in Q4 2014 and held it in 12 quarters.
  • UBS Group's Parexel International Corp position peaked at $218M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.